Hydrophobic Plasmonic Nanoacorn Array for a Label-Free and Uniform SERS-Based Biomolecular Assay

• DOI: 10.1021/acsami.0c03993
• Publication Date: 2020-06-08T14:31:49Z
• Authors: Kai Zhu; Zhuyuan Wang; Shenfei Zong; Yun Liu; Kuo Yang; Na Li; Zhile Wang; Lang Li; Hailong Tang; Yiping Cui
• Keywords: Silver; Receptor, ErbB-2; Metal Nanoparticles; Reproducibility of Results; Biosensing Techniques; 02 engineering and technology; Spectrum Analysis, Raman; Humans; Gold; 0210 nano-technology; Hydrophobic and Hydrophilic Interactions; Nanospheres

A surface-enhanced Raman scattering (SERS) aptasensor based on a hydrophobic assembled nanoacorn (HANA) was developed with improved reproducibility and reduced nonspecific binding effect. In the fabrication process, a hexagonal-packed gold film over nanosphere (AuFON) arrays was first obtained and used as a hydrophobic plasmonic substrate. Then, a uniform sub-3 nm molecular spacer array (containing Raman reporters) was prepared by patterning nanometric hydrophilic ultrathin patches onto the hydrophobic AuFON, in which the hydrophilic thin layer is composed of polymers and aptamers. During the sensing process, the HANA aptasensor smartly impedes the adsorption of SERS probes as Au@Ag nanocubes (Au@Ag NCs) in the absence of targets. In the presence of targets, the displacement of aptamers occurs due to the specific interaction between the targets and the aptamers, and the Au@Ag NCs can be assembled onto the hydrophilic patches on AuFON through electrostatic interactions with polymers. Thus, SERS signals of reporter molecules inside the spacer can be dramatically enhanced due to the formation of a nanoparticle-on-mirror (NPoM) array. In such a SERS aptasensor, the well-ordered distribution of SERS probes ensures excellent repeatability, while the precise subnanometer junctions guarantee high sensitivity. More importantly, since the hydrophobic surface can greatly reduce nonspecific adsorption, the tedious process of nonspecific blocking that is employed in traditional biosensors is no longer needed. Using such a SERS HANA platform, human epidermal growth factor receptor 2 (HER2) and three exosomal proteins were analyzed with high sensitivity and good reproducibility (RSD < 7%) in whole-blood samples.